The specific aim of the SOS-Xience V study is to examine the 12-month incidence of binary angiographic in-stent restenosis after implantation of the Xience V stent in aortocoronary saphenous vein bypass graft lesions.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
the incidence of binary angiographic in-stent restenosis, as assessed by 12 month follow-up quantitative coronary angiography
Timeframe: 12 months